Sentinel node biopsy and standard of care for melanoma
- PMID: 19389531
- DOI: 10.1016/j.jaad.2008.09.067
Sentinel node biopsy and standard of care for melanoma
Abstract
An international panel was convened by the organizing committee of the International Sentinel Node (SN) Society (ISNS) at their meeting in Sydney, Australia, on February 21, 2008, to address questions about SN biopsy (SNB) for melanoma. The panelists subsequently wrote this consensus statement, based on their interpretation of current evidence, as a guide to clinical treatment of patients with clinically localized melanoma. The panel comprised a cross section of expert melanoma surgeons who have contributed data and leadership to investigations of SNB.
Comment in
-
Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma.J Am Acad Dermatol. 2009 Dec;61(6):1079. doi: 10.1016/j.jaad.2009.06.057. J Am Acad Dermatol. 2009. PMID: 19925932 No abstract available.
-
Sentinel node biopsy: not the standard of care for melanoma.J Am Acad Dermatol. 2010 Apr;62(4):708-9. doi: 10.1016/j.jaad.2009.10.003. J Am Acad Dermatol. 2010. PMID: 20227586 No abstract available.
-
Sentinel node biopsy and standard of care for melanoma: a re-evaluation of the evidence.J Am Acad Dermatol. 2010 May;62(5):880-4. doi: 10.1016/j.jaad.2009.08.063. J Am Acad Dermatol. 2010. PMID: 20398815 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical